Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People
Zinan Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiaoyan Nie(Duke University), Yuxuan Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Xue Wang(Peking University), Gengchen Wang(Peking University), Christine Y. Lu(Harvard University), Xiaodong Guan, Xinyi Zhang(Shenyang Agricultural University), Luwen Shi(Peking University), Pengfei Jin(Hainan University), Wen‐Liang Dong(Peking University), Xiaowen Hu(Lanzhou University)
Cited by 1
Related Papers
Effect of Salt Substitution on Cardiovascular Events and Death
|New England Journal of Medicine|2021|726
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
|Nature Microbiology|2016|164
BRAF V600E Expression in Langerhans Cell Histiocytosis
|The American Journal of Surgical Pathology|2014|162
Factors associated with negative conversion of viral RNA in patients hospitalized with COVID-19
|The Science of The Total Environment|2020|158
Aspiration-Related Pulmonary Syndromes
|CHEST Journal|2015|155